These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15330172)

  • 1. Artemisinin induces apoptosis in human cancer cells.
    Singh NP; Lai HC
    Anticancer Res; 2004; 24(4):2277-80. PubMed ID: 15330172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells.
    Singh NP; Lai HC
    Anticancer Res; 2005; 25(6B):4325-31. PubMed ID: 16309236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holotransferrin enhances selective anticancer activity of artemisinin against human hepatocellular carcinoma cells.
    Deng XR; Liu ZX; Liu F; Pan L; Yu HP; Jiang JP; Zhang JJ; Liu L; Yu J
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):862-865. PubMed ID: 24337849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage in dihydroartemisinin-resistant Molt-4 cells.
    Park J; Lai HC; Sasaki T; Singh NP
    Anticancer Res; 2015 Mar; 35(3):1339-43. PubMed ID: 25750283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of artemisinin-tagged holotransferrin on cancer cells.
    Lai H; Sasaki T; Singh NP; Messay A
    Life Sci; 2005 Jan; 76(11):1267-79. PubMed ID: 15642597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression.
    Zhou HJ; Wang Z; Li A
    Anticancer Drugs; 2008 Mar; 19(3):247-55. PubMed ID: 18510170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
    Park J; Lai HC; Singh M; Sasaki T; Singh NP
    Anticancer Res; 2014 Jun; 34(6):2807-10. PubMed ID: 24922643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin.
    Lai H; Singh NP
    Cancer Lett; 1995 May; 91(1):41-6. PubMed ID: 7750093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.
    Nam W; Tak J; Ryu JK; Jung M; Yook JI; Kim HJ; Cha IH
    Head Neck; 2007 Apr; 29(4):335-40. PubMed ID: 17163469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.
    Mu D; Zhang W; Chu D; Liu T; Xie Y; Fu E; Jin F
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):639-45. PubMed ID: 17609948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo.
    Zhang CZ; Zhang H; Yun J; Chen GG; Lai PB
    Biochem Pharmacol; 2012 May; 83(9):1278-89. PubMed ID: 22342732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.
    Nakase I; Gallis B; Takatani-Nakase T; Oh S; Lacoste E; Singh NP; Goodlett DR; Tanaka S; Futaki S; Lai H; Sasaki T
    Cancer Lett; 2009 Feb; 274(2):290-8. PubMed ID: 19006645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine.
    Chan HW; Singh NP; Lai HC
    Anticancer Res; 2013 Oct; 33(10):4389-93. PubMed ID: 24123007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells.
    Wang J; Guo Y; Zhang BC; Chen ZT; Gao JF
    Pharmacology; 2007; 80(4):207-18. PubMed ID: 17622766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells.
    Mu D; Chen W; Yu B; Zhang C; Zhang Y; Qi H
    Methods Find Exp Clin Pharmacol; 2007; 29(1):33-8. PubMed ID: 17344942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells.
    Singh NP; Lai H
    Life Sci; 2001 Nov; 70(1):49-56. PubMed ID: 11764006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro.
    Kim SJ; Kim MS; Lee JW; Lee CH; Yoo H; Shin SH; Park MJ; Lee SH
    J Cancer Res Clin Oncol; 2006 Feb; 132(2):129-35. PubMed ID: 16273420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells.
    Ohgami Y; Elstad CA; Chung E; Shirachi DY; Quock RM; Lai HC
    Anticancer Res; 2010 Nov; 30(11):4467-70. PubMed ID: 21115894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of ethanolic extracts of Artemisia annua to Molt-4 human leukemia cells.
    Singh NP; Ferreira JF; Park JS; Lai HC
    Planta Med; 2011 Nov; 77(16):1788-93. PubMed ID: 21674435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.
    Lee J; Zhou HJ; Wu XH
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):213-20. PubMed ID: 16075280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.